Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04260802 |
Title | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Ocellaris Pharma, Inc. |
Indications |
triple-receptor negative breast cancer |
Therapies |
OC-001 + unspecified PD-L1 antibody |
Age Groups: | senior | adult |
Covered Countries | CAN |